Identification of promoter elements responsible for the regulation of MDR1 from Candida albicans, a major facilitator transporter involved in azole resistance
Upregulation of the MDR1 (multidrug resistance 1) gene is involved in the development of resistance to antifungal agents in clinical isolates of the pathogen Candida albicans. To better understand the molecular mechanisms underlying the phenomenon, the cis-acting regulatory elements present in the MDR1 promoter were characterized using a β-galactosidase reporter system. In an azole-susceptible strain, transcription of this reporter is transiently upregulated in response to either benomyl or H2O2, whereas its expression is constitutively high in an azole-resistant strain (FR2). Two cis-acting regulatory elements within the MDR1 promoter were identified that are necessary and sufficient to confer the same transcriptional responses on a heterologous promoter (CDR2). One, a benomyl response element (BRE), is situated at position −296 to −260 with respect to the ATG start codon. It is required for benomyl-dependent MDR1 upregulation and is also necessary for constitutive high expression of MDR1. A second element, termed H2O2response element (HRE), is situated at position −561 to −520. The HRE is required for H2O2-dependent MDR1 upregulation, but dispensable for constitutive high expression. Two potential binding sites (TTAG/CTAA) for the bZip transcription factor Cap1p (Candida AP-1 protein) lie within the HRE. Moreover, inactivation of CAP1 abolished the transient response to H2O2. Cap1p, which has been previously implicated in cellular responses to oxidative stress, may thus play a trans-acting and positive regulatory role in the H2O2-dependent transcription of MDR1. A minimal BRE (−290 to −273) that is sufficient to detect in vitro sequence-specific binding of protein complexes in crude extracts prepared from C. albicans was also defined. Interestingly, the sequence includes a perfect match to the consensus binding sequence of Mcm1p, raising the possibility that MDR1 may be a direct target of this MADS box transcriptional activator. In conclusion, while the identity of the trans-acting factors that bind to the BRE and HRE remains to be confirmed, the tools developed during this characterization of the cis-acting elements of the MDR1 promoter should now serve to elucidate the nature of the components that modulate its activity.
AlarcoA. M,
RaymondM.
1999; The bZip transcription factor Cap1p is involved in multidrug resistance and oxidative stress response in Candida albicans . J Bacteriol 181:700–708
AlarcoA. M,
BalanI,
TalibiD,
MainvilleN,
RaymondM.
1997; AP1-mediated multidrug resistance in Saccharomyces cerevisiae requires FLR1 encoding a transporter of the major facilitator superfamily. J Biol Chem 272:19304–19313[CrossRef]
Ben-YaacovR,
KnollerS,
CaldwellG. A,
BeckerJ. M,
KoltinY.
1994; Candida albicans gene encoding resistance to benomyl and methotrexate is a multidrug resistance gene. Antimicrob Agents Chemother 38:648–652[CrossRef]
BrocoN,
TenreiroS,
ViegasC. A,
Sa-CorreiaI.
1999; FLR1 gene (ORF YBR008c) is required for benomyl and methotrexate resistance in Saccharomyces cerevisiae and its benomyl-induced expression is dependent on pdr3 transcriptional regulator. Yeast 15:1595–1608[CrossRef]
ColemanD. C,
BennettD. E,
SullivanD. J,
GallagherP. J,
HenmanM. C,
ShanleyD. B,
RussellR. J.
1993; Oral Candida i n HIV infection and AIDS: new perspectives/new approaches. Crit Rev Microbiol 19:61–82[CrossRef]
CosteA,
TurnerV,
IscherF,
MorschhauserJ,
ForcheA,
SelmeckiA,
BermanJ,
BilleJ,
SanglardD.
2006; A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2 , is coupled with loss of heterozygosity at chromosome 5 to mediate antifungal resistance in Candida albicans . Genetics 172:2139–2156
de MicheliM,
BilleJ,
SchuellerC,
SanglardD.
2002; A common drug-responsive element mediates the upregulation of the Candida albicans ABC transporters CDR1 and CDR2 , two genes involved in antifungal drug resistance. Mol Microbiol 43:1197–1214[CrossRef]
FernandesL,
Rodrigues-PousadaC,
StruhlK.
1997; Yap, a novel family of eight bZIP proteins in Saccharomyces cerevisiae with distinct biological functions. Mol Cell Biol 17:6982–6993
FlingM. E,
KopfJ,
TamarkinA,
GormanJ. A,
SmithH. A,
KoltinY.
1991; Analysis of a Candida albicans gene that encodes a novel mechanism for resistance to benomyl and methotrexate. Mol Gen Genet 227:318–329
FranzR,
KellyS. L,
LambD. C,
KellyD. E,
RuhnkeM,
MorschhauserJ.
1998; Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains. Antimicrob Agents Chemother 42:3065–3072
GhannoumM. A,
RexJ. H,
GalgianiJ. N.
1996; Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome. J Clin Microbiol 34:489–495
GuptaV,
KohliA,
KrishnamurthyS,
PuriN,
AalamgeerS. A,
PanwarS,
PrasadR.
1998; Identification of polymorphic mutant alleles of CaMDR1 , a major facilitator of Candida albicans which confers multidrug resistance, and its in vitro transcriptional activation. Curr Genet 34:192–199[CrossRef]
HanahanD.
1985; Techniques for transformation of E. coli . In DNA Cloning: a Practical Approach 1: Core Techniques pp. 109–135 Edited by
GloverD. M.
Oxford: IRL Press;
KeleherC. A,
GoutteC,
JohnsonA. D.
1988; The yeast cell-type-specific repressor alpha 2 acts cooperatively with a non-cell-type-specific protein. Cell 53:927–936[CrossRef]
KugeS,
JonesN.
1994; YAP1 dependent activation of TRX2 is essential for the response of Saccharomyces cerevisiae to oxidative stress by hydroperoxides. EMBO J 13:655–664
LawD,
MooreC. B,
WardleH. M,
GanguliL. A,
KeaneyM. G,
DenningD. W.
1994; High prevalence of antifungal resistance in Candida spp. from patients with AIDS. J Antimicrob Chemother 34:659–668[CrossRef]
MarrK. A,
SeidelK,
WhiteT. C,
BowdenR. A.
2000; Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole. J Infect Dis 181:309–316[CrossRef]
MoranG. P,
SanglardD,
DonnellyS. M,
ShanleyD. B,
SullivanD. J,
ColemanD. C.
1998; Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis . Antimicrob Agents Chemother 42:1819–1830
NguyenD. T,
AlarcoA. M,
RaymondM.
2001; Multiple Yap1p-binding sites mediate induction of the yeast major facilitator FLR1 gene in response to drugs, oxidants, and alkylating agents. J Biol Chem 276:1138–1145[CrossRef]
PassmoreS,
MaineG. T,
ElbleR,
ChristC,
TyeB. K.
1988; Saccharomyces cerevisiae protein involved in plasmid maintenance is necessary for mating of MATα cells. J Mol Biol 204:593–606[CrossRef]
PassmoreS,
ElbleR,
TyeB. K.
1989; A protein involved in minichromosome maintenance in yeast binds a transcriptional enhancer conserved in eukaryotes. Genes Dev 3:921–935[CrossRef]
RottmannM,
DieterS,
BrunnerH,
RuppS.
2003; A screen in Saccharomyces cerevisiae identified CaMCM1 , an essential gene in Candida albicans crucial for morphogenesis. Mol Microbiol 47:943–959[CrossRef]
Sa-CorreiaI,
TenreiroS.
2002; The multidrug resistance transporters of the major facilitator superfamily, 6 years after disclosure of Saccharomyces cerevisiae genome sequence. J Biotechnol 98:215–226[CrossRef]
SanglardD,
OddsF. C.
2002; Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect Dis 2:73–85[CrossRef]
SanglardD,
KuchlerK,
IscherF,
PaganiJ. L,
MonodM,
BilleJ.
1995; Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob Agents Chemother 39:2378–2386[CrossRef]
SanglardD,
IscherF,
MonodM,
BilleJ.
1996; Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors. Antimicrob Agents Chemother 40:2300–2305
SanglardD,
IscherF,
CalabreseD,
MajcherczykP. A,
BilleJ.
1999; The ATP binding cassette transporter gene CgCDR1 from Candida glabrata i s involved in the resistance of clinical isolates to azole antifungal agents. Antimicrob Agents Chemother 43:2753–2765
TenreiroS,
FernandesA. R,
Sa-CorreiaI.
2001; Transcriptional activation of FLR1 gene during Saccharomyces cerevisiae adaptation to growth with benomyl: role of Yap1p and Pdr3p. Biochem Biophys Res Commun 280:216–222[CrossRef]
WangY,
CaoY. Y,
JiaX. M,
CaoY. B,
GaoP. H,
FuX. P,
YingK,
ChenW. S,
JiangY. Y.
2006; Cap1p is involved in multiple pathways of oxidative stress response in Candida albicans . Free Radic Biol Med 40:1201–1209[CrossRef]
WhiteT. C.
1997; Increased mRNA levels of ERG16 , CDR , and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrob Agents Chemother 41:1482–1487
WhiteT. C,
PfallerM. A,
RinaldiM. G,
SmithJ,
ReddingS. W.
1997; Stable azole drug resistance associated with a substrain of Candida albicans from an HIV-infected patient. Oral Dis 3:S102–S109[CrossRef]
WhiteT. C,
MarrK. A,
BowdenR. A.
1998; Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev 11:382–402
WirschingS,
MichelS,
KohlerG,
MorschhauserJ.
2000a; Activation of the multiple drug resistance gene MDR1 in fluconazole-resistant, clinical Candida albicans strains is caused by mutations in a trans -regulatory factor. J Bacteriol 182:400–404[CrossRef]
WirschingS,
MichelS,
MorschhauserJ.
2000b; Targeted gene disruption in Candida albicans wild-type strains: the role of the MDR1 gene in fluconazole resistance of clinical Candida albicans isolates. Mol Microbiol 36:856–865[CrossRef]
ZhangX,
De MicheliM,
ColemanS. T,
SanglardD,
Moye-RowleyW. S.
2000; Analysis of the oxidative stress regulation of the Candida albicans transcription factor, Cap1p. Mol Microbiol 36:618–629
Identification of promoter elements responsible for the regulation of MDR1 from Candida albicans, a major facilitator transporter involved in azole resistance